SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-13-011887
Filing Date
2013-03-25
Accepted
2013-03-25 14:20:17
Documents
1
Period of Report
2013-03-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 2980
  Complete submission text file 0001127602-13-011887.txt   4534
Mailing Address 133 BOSTON POST ROAD WESTON MA 02493
Business Address 133 BOSTON POST ROAD WESTON MA 02493 7814642000
BIOGEN IDEC INC. (Issuer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ENZON PHARMACEUTICALS, INC. 685 ROUTE 202/206 BRIDGEWATER NJ 08807
Business Address
Mulligan Richard (Reporting) CIK: 0001376247 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19311 | Film No.: 13713722